Where Science Meets Security: AI’s Impact on Biotech Cyber Defense

In this episode of AgileTakes, AgileBlue President Tony Pietrocola sits down with Subhashish Dhar, Vice President of IT at BioXcel Therapeutics, to explore how innovation in biotech is intersecting with growing cybersecurity demands. As AI accelerates drug discovery and clinical research, biotech organizations face heightened risks ranging from intellectual property theft to clinical trial disruptions and AI-powered attacks. Subhashish offers real-world insights into the unique challenges the sector faces, and how AI is both amplifying threats and opening new opportunities for stronger defense.